Comparative Pharmacology
Head-to-head clinical analysis: HYDRALAZINE versus MINOXIDIL FOR MEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HYDRALAZINE versus MINOXIDIL FOR MEN.
Hydralazine vs MINOXIDIL (FOR MEN)
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Hydralazine is a direct-acting vasodilator that relaxes arteriolar smooth muscle, leading to decreased peripheral vascular resistance and blood pressure. Its exact mechanism is unclear but may involve interference with calcium movement and increased cGMP levels.
Minoxidil is a direct-acting peripheral vasodilator that opens ATP-sensitive potassium channels in vascular smooth muscle cells, leading to hyperpolarization and relaxation. In hair follicles, it promotes hair growth by increasing blood flow, stimulating prostaglandin synthesis, and prolonging the anagen phase.
10-50 mg orally every 6 hours, titrate to maximum 300 mg/day; 10-20 mg intramuscularly or intravenously every 4-6 hours as needed.
Oral: 2.5-5 mg once daily; may increase to 10 mg once daily if needed. Topical: 5% solution, 1 mL applied to dry scalp twice daily; 5% foam, half a capful applied twice daily; 2% solution, 1 mL applied twice daily.
None Documented
None Documented
Clinical Note
moderateHydralazine + Benzydamine
"Hydralazine may decrease the antihypertensive activities of Benzydamine."
Clinical Note
moderateHydralazine + Droxicam
"Hydralazine may decrease the antihypertensive activities of Droxicam."
Clinical Note
moderateHydralazine + Loxoprofen
"Hydralazine may decrease the antihypertensive activities of Loxoprofen."
Clinical Note
moderateHydralazine + Clonixin
"Hydralazine may decrease the antihypertensive activities of Clonixin."
The terminal elimination half-life of hydralazine is approximately 2-4 hours in patients with normal renal function. However, the duration of antihypertensive effect may be longer (6-12 hours) due to tissue binding and slow release from vascular smooth muscle. In renal impairment, half-life may extend to 7-16 hours, necessitating dose adjustment.
Terminal half-life: 3.5-4.5 hours. Clinical context: Short half-life necessitates twice-daily dosing for hypertension; for topical use, systemic absorption is minimal so half-life less relevant.
Hydralazine is primarily metabolized in the liver via N-acetylation and hydroxylation. Approximately 80-90% of the drug is eliminated in urine as metabolites, with less than 10% excreted unchanged. A small fraction appears in feces via biliary excretion.
Renal: 85-90% (primarily unchanged drug and metabolites). Biliary/fecal: <5%.
Category A/B
Category A/B
Vasodilator
Vasodilator / Hair Growth Stimulant